Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients
John F. Renz, Jennifer Lightdale, Christine Mudge, Peter Bacchetti, Jennifer Watson, Nancy L. Ascher, Jean C. Emond, Philip Rosenthal, John P. Roberts – 30 December 2003 – Triple immunosuppressive therapy using mycophenolate mofetil (MMF), microemulsion cyclosporine (me‐CsA), and prednisone offers the potential for potent immunosuppression without intravenous drug therapy or anti–T‐cell antibody induction therapy.